Stephens analysts adjusted their stance on Paragon 28 , Inc. (NYSE:FNA), downgrading the stock from Overweight to Equal ...
Stephens downgraded Paragon 28 (FNA) to Equal Weight from Overweight with a $13 price target after Zimmer Biomet (ZBH) agreed to acquire the ...
Zimmer Biomet is taking steps to expand its foot and ankle orthopedics business, with a $1.1 billion deal to acquire the ...
Paragon 28, Inc. (FNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
Canaccord analyst Caitlin Cronin downgraded Paragon 28 (FNA) to Hold from Buy with a price target of $13, down from $15, after Zimmer Biomet ...
MVM Partners, LLC, a significant stakeholder in Paragon 28, Inc. (NASDAQ:FNA), disclosed the sale of 111,465 shares of common ...
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (NYSE: FNA) to Zimmer Biomet Holdings, Inc. for $13.00 per share in cash is fair to Paragon 28 ...